A Drug Trial’s Frayed Promise

Friday, April 17, 2015 - 22:20 in Psychology & Sociology

A study of the drug Seroquel XR for patients with borderline personality disorder exposes the tangled mess of interests for academics and universities involved in clinical trials for the pharmaceutical industry.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net